Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-20

Clinical Trial Update: Maternal Serum Adropin in Placenta Accreta Spectrum

View source ↗

Summary

A completed clinical trial investigating maternal serum adropin levels in placenta accreta spectrum (also involving placenta previa) to explore its potential ro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adropin (adropin)

Snippet

Sponsor: Adana City Training and Research Hospital | Conditions: Placenta Accreta Spectrum, Placenta Previa | Status: COMPLETED